儿童与成人鼻咽癌调强放疗长期疗效与后遗症比较
该回顾性研究纳入285例≤18岁鼻咽癌患者,按1:3倾向评分匹配成人患者,比较调强放疗后长期生存与毒性。儿童组5年区域无复发生存和疾病无进展生存优于成人组,但总生存和无远处转移生存无显著差异。成人组3-4级口干、皮肤萎缩、颈部纤维化和放射性脑病发生率更高,儿童组生长迟缓和内分泌功能不全更常见。
要点
- 儿童鼻咽癌调强放疗后5年区域无复发生存和疾病无进展生存优于成人。
- 成人3-4级口干、皮肤萎缩、颈部纤维化及放射性脑病发生率显著更高。
- 儿童需重点关注3-4级生长迟缓和内分泌功能不全。
核心结论
- 儿童鼻咽癌调强放疗后生存结局优于成人且晚期毒性更少。
- 儿童幸存者需高度关注生长发育问题。
研究设计与样本
- 采用倾向评分匹配按1:3筛选成人鼻咽癌患者,最终纳入159例儿童和477例成人。
主要发现
- 儿童与成人5年总生存为89.2%对83.6%(P=.144),无远处转移生存为88.7%对83.5%(P=.124)。
- 儿童与成人5年区域无复发生存为96.4%对89.1%(P=.013),疾病无进展生存为86.5%对77.3%(P=.021)。
- 亚组分析显示年轻年龄是N2-3期总生存、无远处转移生存和区域无复发生存的独立预后因素。
- 儿童最常见后遗症为耳毒性(68.9%),成人最常见为口干(70.8%)。
关键数值与推荐
- 成人3-4级口干发生率为17.6%对儿童8.9%(P=.004)。
- 成人3-4级皮肤萎缩发生率为9.3%对儿童3.7%(P=.022)。
- 成人3-4级颈部纤维化发生率为8.3%对儿童4.4%(P<.001)。
- 成人3-4级放射性脑病发生率为0.8%对儿童0(P=.006)。
- 儿童3-4级生长迟缓和内分泌功能不全发生率为3.0%对成人0.3%(P=.014)。
临床怎么用
- 儿童鼻咽癌调强放疗后需定期监测生长发育和内分泌功能。
- 成人鼻咽癌调强放疗后需重点防治口干、皮肤萎缩、颈部纤维化和放射性脑病。
局限性
- 回顾性研究设计可能存在选择偏倚。
- 儿童样本量有限(159例),亚组分析结果需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Our purpose was to compare long-term survival outcomes and sequelae between child and adult nasopharyngeal carcinoma (NPC) in the era of intensity modulated radiation therapy. METHODS AND MATERIALS: Data on 285 patients with NPC aged ≤18 years at diagnosis and treated with intensity modulated radiation therapy between January 2004 and November 2016 were retrospectively reviewed. A propensity score matching method was adopted to screen matched adult patients with NPC at a ratio of 1:3. Survival outcomes and treatment-related toxicities between child and adult groups were compared. RESULTS: In total, 159 children and 477 adult patients with NPC were included in this study. The 5-year overall survival, distant metastasis-free survival, locoregional relapse-free survival, and disease-free survival between children and adults were 89.2% versus 83.6% (P = .144), 88.7% versus 83.5% (P = .124), 96.4% versus 89.1% (P = .013), and 86.5% versus 77.3% (P = .021), respectively. Subgroup analyses revealed that the young age was an independent prognostic factor of overall survival, distant metastasis-free survival, and locoregional relapse-free survival in the advanced N stage (N2-3) group and disease-free survival in the advanced T stage (T3-4) group and N2-3 and stage III-IVA groups. The most common sequela was ototoxicity (68.9%) in child patients and xerostomia (70.8%) in adult patients. Adult survivors had a significantly higher incidence of grade 3 to 4 late toxicities in xerostomia (17.6% vs 8.9%; P = .004), skin dystrophy (9.3% vs 3.7%; P = .022), neck fibrosis (8.3% vs 4.4%; P < .001), and radiation encephalopathy (0.8% vs 0; P = .006). Child survivors were more likely to develop grade 3 to 4 growth retardation and endocrine insufficiency (3.0% vs 0.3%; P = .014). CONCLUSIONS: Child patients with NPC achieved significantly better survival outcomes but fewer late toxicities than adult patients. However, we should pay great attention to growth problems of child survivors.
引用
- Chen BB, Lu SY, Peng H, et al. Comparison of Long-Term Outcomes and Sequelae Between Children and Adult Nasopharyngeal Carcinoma Treated With Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys. 2019. PMID: 31794839. doi:10.1016/j.ijrobp.2019.11.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。